{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:57:48Z","timestamp":1794243468361,"version":"4.9.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Infective endocarditis (IE) can be complicated by vertebral osteomyelitis (VO). This study investigates risk factors associated with VO in patients with infective endocarditis, and 6-month mortality and relapse rates in patients with IE and concomitant VO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a observational study in two hospitals between September 2016 and October 2022. Patients with possible or definite IE according European Society of Cardiology (2015) modified criteria were retrieved from the local endocarditis team registries. The VO diagnosis was based on radiological signs, irrespective of clinical symptoms. Multivariable logistic regression analysis was performed to identify risk factors for vertebral osteomyelitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 633 consecutive patients with IE. A total of 229 (36.2%) patients had prosthetic valves and 127 (20.1%) had cardiac implantable electronic devices. The most frequent causative micro-organism was\n                      <jats:italic>Streptococcus species<\/jats:italic>\n                      (217, 34.3%), followed by\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (167, 26.4%). VO was diagnosed in 73 patients (11.5%, 95% CI 9.0%-14.0%).\n                      <jats:italic>Enterococcus spp.<\/jats:italic>\n                      (OR 2.48, 95% CI 1.31\u20134.52) and age (OR 1.04 per year, 95% CI 1.02\u20131.06) were independently associated with concomitant VO. The 6-month mortality risk did not differ between patients with (16\/73, 21.9%) or without (110\/560, 19.6%) VO (HR 1.13, 95% CI 0.67\u20131.91). Relapse rate was higher in patients with VO but the difference was not statistically significant (16.1 vs. 7.5%, OR 3.62, 95% CI 0.94\u201313.34).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Twelve percent of patients with IE also had VO. Among older patients and patients with IE caused by enterococci, there should be a higher index of suspicion for vertebral infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10096-025-05041-8","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T03:47:24Z","timestamp":1737431244000},"page":"819-825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vertebral osteomyelitis in patients with infective endocarditis: prevalence, risk factors and mortality"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-4627","authenticated-orcid":false,"given":"S.","family":"Douiyeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. C. E.","family":"Sigaloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. G.","family":"Ulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G. J.","family":"Duffels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Drexhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Germans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.P.","family":"Wagenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. T. P.","family":"Buis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. W.","family":"van der Vaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. H.","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. A. W. M.","family":"Umans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"5041_CR1","unstructured":"de S\u00e8ze S, Ryckewaert A, Kahn MF, Simonin JL, Heuleu JN (Dec 1965) [Osler\u2019s endocarditis in rheumatology]. (in Fre), Rev Rhum Mal Osteoartic, L\u2019endocardite d\u2019Osler en rhumatologie 32(12):739\u2013744."},{"key":"5041_CR2","doi-asserted-by":"publisher","unstructured":"Carbone A et al (Dec 2020) Spondylodiscitis complicating infective endocarditis, Heart 106(24):1914\u20131918. https:\/\/doi.org\/10.1136\/heartjnl-2019-316492","DOI":"10.1136\/heartjnl-2019-316492"},{"key":"5041_CR3","doi-asserted-by":"publisher","unstructured":"Pace SD et al (Apr 15 2021) Endocarditis with spondylodiscitis: clinical characteristics and prognosis. BMC Cardiovasc Disord 21(1):186. https:\/\/doi.org\/10.1186\/s12872-021-01991-x","DOI":"10.1186\/s12872-021-01991-x"},{"issue":"4","key":"5041_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s10156-010-0046-8","volume":"16","author":"K Tamura","year":"2010","unstructured":"Tamura K (2010) Clinical characteristics of infective endocarditis with vertebral osteomyelitis. J Infect Chemother 16(4):260\u2013265. 01\/01\/2010 https:\/\/doi.org\/10.1007\/s10156-010-0046-8","journal-title":"J Infect Chemother"},{"key":"5041_CR5","doi-asserted-by":"publisher","unstructured":"Le Moal G et al (Sep 2002) Clinical and laboratory characteristics of infective endocarditis when associated with spondylodiscitis. Eur J Clin Microbiol Infect Dis 21(9):671\u2013675. https:\/\/doi.org\/10.1007\/s10096-002-0798-x","DOI":"10.1007\/s10096-002-0798-x"},{"key":"5041_CR6","doi-asserted-by":"publisher","unstructured":"Berbari EF et al (2015) Infectious Diseases Society of America (IDSA) Clinical Practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis 61(6):e26-46, Sep 15 2015, https:\/\/doi.org\/10.1093\/cid\/civ482","DOI":"10.1093\/cid\/civ482"},{"key":"5041_CR7","doi-asserted-by":"publisher","unstructured":"Castagne B et al (May 2021) A six-week antibiotic treatment of endocarditis with spondylodiscitis is not associated with increased risk of relapse: a retrospective cohort study. Infect Dis Now 51(3):253\u2013259. https:\/\/doi.org\/10.1016\/j.medmal.2020.10.026","DOI":"10.1016\/j.medmal.2020.10.026"},{"key":"5041_CR8","doi-asserted-by":"publisher","unstructured":"Slipczuk L et al (2013) Infective endocarditis epidemiology over five decades: a systematic review, (in eng), PLoS One 8(12):e82665. https:\/\/doi.org\/10.1371\/journal.pone.0082665","DOI":"10.1371\/journal.pone.0082665"},{"key":"5041_CR9","doi-asserted-by":"publisher","unstructured":"Habib G et al (2015) ESC guidelines for the management of infective endocarditis: the Task Force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-thoracic surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J, 36, 44, pp. 3075\u20133128, Nov 21 2015, https:\/\/doi.org\/10.1093\/eurheartj\/ehv319","DOI":"10.1093\/eurheartj\/ehv319"},{"key":"5041_CR10","doi-asserted-by":"publisher","unstructured":"Kouijzer IJE et al (May 2018) The diagnostic value of (18)F-FDG-PET\/CT and MRI in suspected vertebral osteomyelitis - a prospective study, (in eng). Eur J Nucl Med Mol Imaging 45(5):798\u2013805. https:\/\/doi.org\/10.1007\/s00259-017-3912-0","DOI":"10.1007\/s00259-017-3912-0"},{"key":"5041_CR11","unstructured":"d. A. B. T. W. van der Vaart, prof. dr. J.W. Deckers, dr. E.H. Natour, dr. N. J. Verkaik, Dr. J.T.M. van der Meer SWAB guidelines for the antimicrobial treatment of infective endocarditis, ed. Stichting Werkgroep Antibioticabeleid"},{"key":"5041_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad193","author":"V Delgado","year":"2023","unstructured":"Delgado V et al (2023) 2023 ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehad193","journal-title":"Eur Heart J"},{"key":"5041_CR13","doi-asserted-by":"publisher","unstructured":"Conan Y et al (2021) Large increase of vertebral osteomyelitis in France: a 2010\u20132019 cross-sectional study, Epidemiol Infect vol. 149, p. e227, Oct 6. https:\/\/doi.org\/10.1017\/S0950268821002181","DOI":"10.1017\/S0950268821002181"},{"key":"5041_CR14","doi-asserted-by":"publisher","unstructured":"Ricci C et al (Oct 1990) Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. (in Eng), Radiology 177(1):83\u2013\u20098 https:\/\/doi.org\/10.1148\/radiology.177.1.2399343.","DOI":"10.1148\/radiology.177.1.2399343"},{"key":"5041_CR15","doi-asserted-by":"publisher","unstructured":"Harkonen M, Olin PE, Wennstrom J (1981) Severe backache as a presenting sign of bacterial endocarditis, Acta Med Scand 210(4):329\u2013\u200931. https:\/\/doi.org\/10.1111\/j.0954-6820.1981.tb09825.x","DOI":"10.1111\/j.0954-6820.1981.tb09825.x"},{"key":"5041_CR16","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez Guerrero ML, Goyenechea A, Verdejo C, Roblas RF, de G\u00f3rgolas M (Nov 2007) Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome, (in eng), Medicine (Baltimore) 86(6):363\u2013377https:\/\/doi.org\/10.1097\/MD.0b013e31815d5386","DOI":"10.1097\/MD.0b013e31815d5386"},{"issue":"5","key":"5041_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1086\/341977","volume":"35","author":"EN Vergis","year":"2002","unstructured":"Vergis EN et al (2002) Association between the Presence of Enterococcal virulence factors Gelatinase, Hemolysin, and Enterococcal Surface Protein and mortality among patients with Bacteremia due to Enterococcus faecalis. Clin Infect Dis 35(5):570\u2013575. https:\/\/doi.org\/10.1086\/341977","journal-title":"Clin Infect Dis"},{"key":"5041_CR18","doi-asserted-by":"publisher","unstructured":"McCormick JK, Hirt H, Dunny GM, Schlievert PM (Aug 2000) Pathogenic mechanisms of Enterococcal Endocarditis, (in eng). Curr Infect Dis Rep 2(4):315\u2013321. https:\/\/doi.org\/10.1007\/s11908-000-0009-9","DOI":"10.1007\/s11908-000-0009-9"},{"key":"5041_CR19","doi-asserted-by":"publisher","unstructured":"Smids C et al (Feb 2017) A comparison of the diagnostic value of MRI and (18)F-FDG-PET\/CT in suspected spondylodiscitis, (in eng), Infection 45(1):41\u201349. https:\/\/doi.org\/10.1007\/s15010-016-0914-y","DOI":"10.1007\/s15010-016-0914-y"},{"key":"5041_CR20","doi-asserted-by":"publisher","unstructured":"van der Vaart TW et al (2023) Positive impact of [18F]FDG-PET\/CT on mortality in patients with Staphylococcus aureus bacteremia explained by immortal time bias, (in eng), Clin Infect Dis. 4. https:\/\/doi.org\/10.1093\/cid\/ciad112","DOI":"10.1093\/cid\/ciad112"},{"key":"5041_CR21","doi-asserted-by":"publisher","unstructured":"Kang DH et al (Jun 28 2012) Early surgery versus conventional treatment for infective endocarditis, (in eng). N Engl J Med 366:2466\u20132473. https:\/\/doi.org\/10.1056\/NEJMoa1112843","DOI":"10.1056\/NEJMoa1112843"},{"key":"5041_CR22","doi-asserted-by":"publisher","unstructured":"Kim DH et al (Sep 14 2010) Impact of early surgery on embolic events in patients with infective endocarditis, (in eng), Circulation 122(11) Suppl, pp. S17-22. https:\/\/doi.org\/10.1161\/circulationaha.109.927665","DOI":"10.1161\/circulationaha.109.927665"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05041-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:07:50Z","timestamp":1743253670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05041-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5041"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05041-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is an observational study. The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Amsterdam UMC (Date 12-10-2023.\/No METC2023.0424). In the Noordwest Hospital the Research Ethics Committee has confirmed that no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Dr. van Werkhoven has received grants from DaVolterra, bioMerieux and LimmaTech which were paid to the institution. Dr. van Werkhoven has received consulting fees from Merck\/MSD and Sanofi-Pasteur in regards to pneumococcal vaccines. These payments were made to the institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}